Suministro de medicamento exclusivo Bulevirtida (HEPCLUDEX)
TED · 610605-2026Award noticeawardedNo deadline given
Buyer
NameServicio Madrileno de Salud, Hospital Universitario La Paz
CountryES
Published2026-09-04
Deadline—
Who already wins at this buyer
Firms with recorded awards from Servicio Madrileno de Salud, Hospital Universitario La Paz in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE FARMA, S.A.U. | 2 | €2,779,646 | 2026-06-15 |
| BRISTOL-MYERS SQUIBB, S.A.U. | 2 | €824,543 | 2026-06-29 |
| ABBVIE SPAIN, S.L.U. | 2 | €319,559 | 2026-10-01 |
| BIOGEN SPAIN, S.L. | 1 | €2,964,125 | 2026-09-15 |
| ALEXION PHARMA SPAIN S.L.U. | 1 | €2,603,216 | 2026-09-09 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Suministro de medicamento exclusivo Bulevirtida (HEPCLUDEX)
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-12 | Suministro de BULEVIRTIDA (HEPCLUDEX) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos | HOSPITAL CLINICO SAN CARLOS ES | 95% |
| 2026-05-29 | SUMINISTRO DE MEDICAMENTO EXCLUSIVO: SELADELPAR (LYVDELZI) | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 93% |
| 2026-08-19 | Suministro de Medicamento Exclusivo Lutathera-Lutecio Laboratorio Novartis Farmacéutica S.A. | HOSPITAL UNIVERSITARIO DE GETAFE ES | 93% |
| 2026-06-09 | SUMINISTRO DEL MEDICAMENTO EXCLUSIVO: LEBRIKIZUMAB (EBGLYSS) | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 93% |
| 2026-08-25 | Suministro de Empapadores | Servicio Madrileño de Salud - Hospital Universitario La Paz ES | 93% |
| 2026-09-09 | Suministro del medicamento exclusivo: Ravulizumab (ULTOMIRIS). | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 92% |